サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1326578

僧帽弁疾患の世界市場規模調査＆予測、タイプ別、適応症別、エンドユーザー別、地域別分析、2023-2030年

Global Mitral Valve Disease Market Size Study & Forecast, by Type, by Indication, by End User and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
僧帽弁疾患の世界市場規模調査＆予測、タイプ別、適応症別、エンドユーザー別、地域別分析、2023-2030年
出版日: 2023年07月28日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

僧帽弁疾患の世界市場は、2022年には約27億2,000万米ドルと評価され、予測期間2023-2030年には8.8％以上の健全な成長率で成長すると予測されています。

僧帽弁疾患とは、左心房と左心室間の血流調節を担う心臓の4つの弁の1つである僧帽弁に影響を及ぼす病状を指します。この疾患には、僧帽弁逆流、僧帽弁狭窄、僧帽弁逸脱を含む僧帽弁の様々な異常が含まれます。僧帽弁治療市場は、僧帽弁疾患に対する個人の意識の高まり、高血圧、高コレステロールなどの危険因子の有病率の増加、生活習慣の変化などの要因により成長を経験しています。これらの要因は総体的に僧帽弁治療製品に対する需要の増加に寄与し、世界全体の市場成長を牽引しています。

僧帽弁閉鎖不全症（MR）の有病率の増加は、主に僧帽弁疾患市場の拡大を促進しています。2021年に発表された米国国立衛生研究所の報告書によると、僧帽弁閉鎖不全症（MR）は世界規模で最も流行している弁膜症であるという特徴を持っています。僧帽弁閉鎖不全症は全人口の2％以上に影響を与え、その有病率は年齢が進むにつれて上昇します。市場の成長は、僧帽弁疾患を治療するための低侵襲手技に対する需要の増加や、この分野における低侵襲製品のその後の進歩や開拓によってさらに後押しされています。しかし、僧帽弁疾患市場の成長は、僧帽弁の修復および置換手術手順に関連する多額の費用、ならびに2023-2030年の予測期間を通じて僧帽弁心臓弁および医薬品の開発、使用、および承認に対して新興国市場が課す厳しい規制によって妨げられています。

僧帽弁疾患の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、整備されたヘルスケアインフラ、僧帽弁疾患に関する消費者の意識の高さ、米国における主要プレイヤーの存在、僧帽弁治療分野における幅広い製品群により、2022年の市場を独占しました。アジア太平洋地域は、中国やインドのような国における大規模な人口基盤やヘルスケア支出の増加などの要因により、予測期間中に最も急成長することが期待されています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 僧帽弁疾患の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 僧帽弁疾患の世界市場力学

  • 僧帽弁疾患市場の影響分析（2020-2030年）
    • 市場促進要因
      • 僧帽弁疾患に対する個人の意識の高まり
      • 高血圧、高コレステロール、生活習慣の変化などの危険因子の増加
    • 市場の課題
      • 僧帽弁置換術および修復術の高コスト
      • 政府機関による厳しい規制
    • 市場機会
      • 低侵襲製品の処方の進歩
      • 僧帽弁疾患を治療するための低侵襲手技に対する需要の増加

第4章 僧帽弁疾患の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 僧帽弁疾患の世界市場：タイプ別

  • 市場スナップショット
  • 僧帽弁疾患の世界市場：タイプ別、実績 - ポテンシャル分析
  • 僧帽弁疾患の世界市場：タイプ別推定・予測：2020-2030年
  • 僧帽弁疾患市場、サブセグメント別分析
    • 僧帽弁修復
    • 僧帽弁置換術
    • 心臓再同期療法
    • 僧帽弁治療薬

第6章 僧帽弁疾患の世界市場：適応症別

  • 市場スナップショット
  • 僧帽弁疾患の世界市場：適応症別、実績 - ポテンシャル分析
  • 僧帽弁疾患の世界市場：適応症別推定・予測、2020-2030年
  • 僧帽弁疾患市場、サブセグメント分析
    • 僧帽弁狭窄症
    • 僧帽弁逸脱
    • 僧帽弁逆流

第7章 僧帽弁疾患の世界市場：エンドユーザー別

  • 市場スナップショット
  • 僧帽弁疾患の世界市場：エンドユーザー別、実績 - ポテンシャル分析
  • 僧帽弁疾患の世界市場：エンドユーザー別推定・予測、2020-2030年
  • 僧帽弁疾患市場のサブセグメント分析
    • 病院
    • 外来手術センター
    • その他

第8章 僧帽弁疾患の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 僧帽弁疾患市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプの推定・予測、2020-2030年
      • 適応症の推定・予測、2020-2030年
      • エンドユーザーの推定・予測、2020～2030年
    • カナダ
  • 欧州僧帽弁疾患市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋僧帽弁疾患市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ僧帽弁疾患市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Teva Pharmaceutical Industries Ltd.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Corcym UK Limited
    • Abbott Laboratories
    • Zydus Lifesciences Limited
    • Medtronic plc
    • Edwards Lifesciences Corporation
    • Affluent Medical
    • ShockWave Medical, Inc.
    • Valcare Medical
    • Pfizer Inc

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Mitral Valve Disease Market, report scope
  • TABLE 2. Global Mitral Valve Disease Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Mitral Valve Disease Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global Mitral Valve Disease Market estimates & forecasts by Indication 2020-2030 (USD Billion)
  • TABLE 5. Global Mitral Valve Disease Market estimates & forecasts by End User 2020-2030 (USD Billion)
  • TABLE 6. Global Mitral Valve Disease Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Mitral Valve Disease Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Mitral Valve Disease Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Mitral Valve Disease Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Mitral Valve Disease Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Mitral Valve Disease Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Mitral Valve Disease Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Mitral Valve Disease Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Mitral Valve Disease Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Mitral Valve Disease Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Mitral Valve Disease Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Mitral Valve Disease Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Mitral Valve Disease Market
  • TABLE 71. List of primary sources, used in the study of global Mitral Valve Disease Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Mitral Valve Disease Market, research methodology
  • FIG 2. Global Mitral Valve Disease Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Mitral Valve Disease Market, key trends 2022
  • FIG 5. Global Mitral Valve Disease Market, growth prospects 2023-2030
  • FIG 6. Global Mitral Valve Disease Market, porters 5 force model
  • FIG 7. Global Mitral Valve Disease Market, pest analysis
  • FIG 8. Global Mitral Valve Disease Market, value chain analysis
  • FIG 9. Global Mitral Valve Disease Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Mitral Valve Disease Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Mitral Valve Disease Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Mitral Valve Disease Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Mitral Valve Disease Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Mitral Valve Disease Market, regional snapshot 2020 & 2030
  • FIG 15. North America Mitral Valve Disease Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Mitral Valve Disease Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Mitral Valve Disease Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Mitral Valve Disease Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Mitral Valve Disease Market 2020 & 2030 (USD Billion)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

目次

Global Mitral Valve Disease Market is valued at approximately USD 2.72 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.8% over the forecast period 2023-2030. Mitral valve disease refers to a medical condition that affects the mitral valve, which is one of the heart's four valves responsible for regulating blood flow between the left atrium and left ventricle. The disease encompasses various abnormalities of the mitral valve, including mitral regurgitation, mitral stenosis, and mitral valve prolapse. The market for mitral valve treatment is experiencing growth due to factors such as the rising awareness among individuals about mitral valve disease, the increasing prevalence of risk factors such as high blood pressure, high cholesterol, and changes in lifestyle habits. These factors collectively contribute to the growing demand for mitral valve treatment products and drive the overall market growth across the globe

The increasing prevalence of Mitral regurgitation (MR) is primarily driving the expansion of the mitral valve disease market. As per the National Institutes of Health report released in 2021, mitral regurgitation (MR) holds the distinction of being the most prevalent valvular abnormality on a global scale. It impacts more than 2% of the entire population and exhibits a prevalence that rises with advancing age. The market growth is further propelled by the increasing demand for minimally invasive procedures to treat mitral valve diseases, as well as the subsequent advancements and development of minimally invasive products in this field. However, the growth of the market for mitral valve disease is hindered by the substantial costs associated with the repair and replacement surgeries procedures of the mitral valve, as well as the stringent regulations imposed by governing bodies for the development, usage, and approval of mitral heart valves and medications throughout the forecast period of 2023-2030.

The key regions considered for the Global Mitral Valve Disease Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of well-developed healthcare infrastructure, higher consumer awareness regarding mitral valve diseases, the presence of major players in the United States, and a wide range of offerings in the mitral valve treatment sector. Asia Pacific is expected to fastest growing region during the forecast period, owing to factors such as the large population base and the rising healthcare expenditure in countries such as China and India.

Major market players included in this report are:

  • Teva Pharmaceutical Industries Ltd.
  • Corcym UK Limited
  • Abbott Laboratories
  • Zydus Lifesciences Limited
  • Medtronic plc
  • Edwards Lifesciences Corporation
  • Affluent Medical
  • ShockWave Medical, Inc.
  • Valcare Medical
  • Pfizer Inc.

Recent Developments in the Market:

  • In November 2021, Medtronic plc. released preliminary data on the Intrepid transcatheter mitral valve replacement (TMVR) system, which was used in patients with severe and symptomatic mitral valve regurgitation (MR) through the transfemoral access route. The data from the initial five patients enrolled in an Early Feasibility Study of the Intrepid Transfemoral System demonstrated a 100% survival rate with no reported strokes.
  • In June 2021, Gyrus Capital acquired LivaNova Plc.'s heart valve company and formed a new global medical device company named it as Corcym. This independent company aims to focus on delivering optimal solutions to combat structural heart disease for patients and heart surgeons.

Global Mitral Valve Disease Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Indication, End User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Mitral Valve Repair
  • Mitral Valve Replacement
  • Cardiac Resynchronization Therapy
  • Mitral Valve Therapeutics

By Indication:

  • Mitral Valve Stenosis
  • Mitral Valve Prolapse
  • Mitral Valve Regurgitation

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Mitral Valve Disease Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Mitral Valve Disease Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Mitral Valve Disease Market, by Indication, 2020-2030 (USD Billion)
    • 1.2.4. Mitral Valve Disease Market, by End User, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Mitral Valve Disease Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Mitral Valve Disease Market Dynamics

  • 3.1. Mitral Valve Disease Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising awareness among individuals about mitral valve disease
      • 3.1.1.2. Increasing prevalence of risk factors such as high blood pressure, high cholesterol, and changes in lifestyle habits
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of mitral valve replacement and repair procedures
      • 3.1.2.2. Stringent regulations imposed by governing bodies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in Formulation of minimally invasive products
      • 3.1.3.2. Increasing demand for minimally invasive procedures to treat mitral valve diseases

Chapter 4. Global Mitral Valve Disease Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Mitral Valve Disease Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Mitral Valve Disease Market by Type, Performance - Potential Analysis
  • 5.3. Global Mitral Valve Disease Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Mitral Valve Disease Market, Sub Segment Analysis
    • 5.4.1. Mitral Valve Repair
    • 5.4.2. Mitral Valve Replacement
    • 5.4.3. Cardiac Resynchronization Therapy
    • 5.4.4. Mitral Valve Therapeutics

Chapter 6. Global Mitral Valve Disease Market, by Indication

  • 6.1. Market Snapshot
  • 6.2. Global Mitral Valve Disease Market by Indication, Performance - Potential Analysis
  • 6.3. Global Mitral Valve Disease Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
  • 6.4. Mitral Valve Disease Market, Sub Segment Analysis
    • 6.4.1. Mitral Valve Stenosis
    • 6.4.2. Mitral Valve Prolapse
    • 6.4.3. Mitral Valve Regurgitation

Chapter 7. Global Mitral Valve Disease Market, by End User

  • 7.1. Market Snapshot
  • 7.2. Global Mitral Valve Disease Market by End User, Performance - Potential Analysis
  • 7.3. Global Mitral Valve Disease Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
  • 7.4. Mitral Valve Disease Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Others

Chapter 8. Global Mitral Valve Disease Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Mitral Valve Disease Market, Regional Market Snapshot
  • 8.4. North America Mitral Valve Disease Market
    • 8.4.1. U.S. Mitral Valve Disease Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Indication breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Mitral Valve Disease Market
  • 8.5. Europe Mitral Valve Disease Market Snapshot
    • 8.5.1. U.K. Mitral Valve Disease Market
    • 8.5.2. Germany Mitral Valve Disease Market
    • 8.5.3. France Mitral Valve Disease Market
    • 8.5.4. Spain Mitral Valve Disease Market
    • 8.5.5. Italy Mitral Valve Disease Market
    • 8.5.6. Rest of Europe Mitral Valve Disease Market
  • 8.6. Asia-Pacific Mitral Valve Disease Market Snapshot
    • 8.6.1. China Mitral Valve Disease Market
    • 8.6.2. India Mitral Valve Disease Market
    • 8.6.3. Japan Mitral Valve Disease Market
    • 8.6.4. Australia Mitral Valve Disease Market
    • 8.6.5. South Korea Mitral Valve Disease Market
    • 8.6.6. Rest of Asia Pacific Mitral Valve Disease Market
  • 8.7. Latin America Mitral Valve Disease Market Snapshot
    • 8.7.1. Brazil Mitral Valve Disease Market
    • 8.7.2. Mexico Mitral Valve Disease Market
  • 8.8. Middle East & Africa Mitral Valve Disease Market
    • 8.8.1. Saudi Arabia Mitral Valve Disease Market
    • 8.8.2. South Africa Mitral Valve Disease Market
    • 8.8.3. Rest of Middle East & Africa Mitral Valve Disease Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Teva Pharmaceutical Industries Ltd.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Corcym UK Limited
    • 9.3.3. Abbott Laboratories
    • 9.3.4. Zydus Lifesciences Limited
    • 9.3.5. Medtronic plc
    • 9.3.6. Edwards Lifesciences Corporation
    • 9.3.7. Affluent Medical
    • 9.3.8. ShockWave Medical, Inc.
    • 9.3.9. Valcare Medical
    • 9.3.10. Pfizer Inc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption